Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Aimovig (erenumab)
pCPA File Number:
21286
Negotiation Status:
Active Negotiation
Indication(s):
migraine, chronic
Sponsor/Manufacturer:
NOVARTIS PHARMACEUTICALS CANADA INC
CADTH Project Number:
SR0578-000
pCPA Engagement Letter Issued:
2021-01-25
Negotiation Process Concluded:
Not Applicable